Clinical significance of hyperhomocysteinemia in infective endocarditis A case-control study

Medicine (United States)

Volumn 95, Issue 39, 2016, Pages

  Iossa, Domenico ^a   Molaro, Rosa ^a   Andini, Roberto ^a   Parrella, Antonio ^a   Ursi, Maria Paola ^a   Mattucci, Irene ^a   De Vincentiis, Lucia ^c   Dialetto, Giovanni ^d   Utili, Riccardo ^a,b   Durante Mangoni, Emanuele ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b AORN dei Colli Monaldi   (Italy)

^c Unit of Clinical Biochemistry   (Italy)

^d MONALDI HOSPITAL   (Italy)

Author keywords

Embolism; Endocarditis; Homeostasis; Infective; Mortality; Thrombosis

Indexed keywords

BIOLOGICAL MARKER; HOMOCYSTEINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD LEVEL; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EMBOLISM; FEMALE; HOSPITALIZATION; HUMAN; HYPERHOMOCYSTEINEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ODDS RATIO; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VALVULAR HEART DISEASE; BLOOD; COMPLICATION; ENDOCARDITIS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; ENDOCARDITIS; FEMALE; HEART VALVE DISEASES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 85013178243     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004972     Document Type: Article

References (21)

1. Hoen B, Duval X. Infective endocarditis. N Engl J Med 2013;369:785.
2. Werdan K, Dietz S, Löffler B, et al. Mechanisms of infective endocarditis: pathogen-host interaction and risk states. Nat Rev Cardiol 2014; 11:35-50.
3. Que YA, Moreillon P. Infective endocarditis. Nat Rev Cardiol 2011;8:322-36.
4. Durante-Mangoni E, Molaro R, Iossa D. The role of hemostasis in infective endocarditis. Curr Infect Dis Rep 2014;16:435-43.
5. Durante-Mangoni E, Iossa D, Molaro R, et al. Prevalence and significance of two major inherited thrombophilias in infective endocarditis. Inter Emerg Med 2015;10:587-94.
6. Schouten M, Wiersinga WJ, Levi M, et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008;83:536-45.
7. Verhamme P, Hoylaerts MF. Hemostasis and inflammation: two of a kind? Thromb J 2009;7:15-8.
8. Eldibany MM, Caprini JA. Hyperhomocysteine and thrombosis: an overview. Arch Pathol Lab Med 2007;131:872-84.
9. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999;81:165-76.
10. Homocysteine Studies CollaborationHomocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288: 2015-22.
11. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999;340:1555-64.
12. Antoniades C, Antonopoulos AS, Tousoulis D, et al. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 2009;30:6-15.
13. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999; 99:178-82.
14. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetra hydrofolate reductase. Nat Genet 1995;10:111-3.
15. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004;50:3-2.
16. Durante Mangoni E, Adinolfi LE, Tripodi MF, et al. Risk factors for 'major' embolic events in hospitalized patients with infective endocarditis. Am Heart J 2003;146:55-61.
17. Inanir A, Yigit S, Tural S, et al. MTHFR gene C677T mutation and ACE gene I/D polymorphism in Turkish patients with osteoarthritis. Dis Markers 2013;34:17-22.
18. Moreillon P, Que YA, Bayer AS. Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am 2002;16: 297-318.
19. Widmer E, Que YA, Entenza JM, et al. New concepts in the pathophysiology of infective endocarditis. Curr Infect Dis Rep 2006; 8:271-9.
20. Durante-Mangoni E, Iossa D, Nappi F, et al. Inherited hyperhomocysteinemia as a cause of nonbacterial thrombotic endocarditis. J Heart Valve Dis 2011;20:232-3.
21. Durante-Mangoni E, Nappi G. Giant endocarditis vegetation on a pacemaker lead. Intern Emerg Med 2010;5:251-2.